Literature DB >> 6087870

Catalase depression in malignant liver from chickens with myeloblastosis and Marek's disease.

D L Williams-Smith, L N Payne, S J Wyard.   

Abstract

In rapidly frozen livers from chickens affected with myeloblastosis and Marek's disease and from unaffected control birds there exists a strong correlation between catalase activity and catalase Electron Paramagnetic Resonance (EPR) signal intensities. The diseased chickens had activities and signals reduced to as little as 10% of control values. There were no changes in the EPR parameters in diseased liver and the data support the hypothesis that the lowering in activity is due to lowered catalase levels rather than to catalase inhibition. The rate of transformation of catalase to catalase-formate in liver was studied by freeze-clamping liver in anaesthetised chickens, then warming to 37 degrees for 1 or 2 minutes anaerobiosis, and then refreezing. The only difference of significance in this transformation between diseased and normal livers was the greater percentage of total catalase present as catalase-formate (approximately + 15%) in aerobic diseased liver, which may indicate a lowered production of hydrogen peroxide, relative to formate, in these livers. The rate of transformation was far faster in chickens (t1/2 less than 1 min) than in the rat (t1/2 = 7.7 min).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087870      PMCID: PMC1976782          DOI: 10.1038/bjc.1984.189

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  IMMUNOCHEMICAL STUDIES ON LIVER AND ERYTHROCYTE CATALASES FROM CATTLE, HORSE, RABBIT AND HUMAN.

Authors:  A SAHA; D H CAMPBELL; W A SCHROEDER
Journal:  Biochim Biophys Acta       Date:  1964-04-06

2.  The in vitro inhibition of catalase by a tumor factor.

Authors:  A B HARGREAVES; H F DEUTSCH
Journal:  Cancer Res       Date:  1952-10       Impact factor: 12.701

3.  Induced changes in the electron paramagnetic resonance spectra of mammalian catalases.

Authors:  D L Williams-Smith; K Patel
Journal:  Biochim Biophys Acta       Date:  1975-10-20

4.  The properties of hydrogen peroxide production under hyperoxic and hypoxic conditions of perfused rat liver.

Authors:  N Oshino; D Jamieson; B Chance
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

5.  Liver catalase. II. Catalase fractions from normal and tumor-bearing rats.

Authors:  V E PRICE; R E GREENFIELD
Journal:  J Biol Chem       Date:  1954-07       Impact factor: 5.157

6.  Immunological evidence of repressed catalase synthesis in livers of tumor-bearing mice.

Authors:  E T NISHIMURA; T Y KOBARA; J P KALTENBACH; W B WARTMAN
Journal:  Arch Biochem Biophys       Date:  1962-06       Impact factor: 4.013

7.  Superoxide dismutase activity in WI-38 cell cultures: effects of age, trypsinization and SV-40 transformation.

Authors:  N Yamanaka; D Deamer
Journal:  Physiol Chem Phys       Date:  1974

8.  The role of H 2 O 2 generation in perfused rat liver and the reaction of catalase compound I and hydrogen donors.

Authors:  N Oshino; B Chance; H Sies; T Bücher
Journal:  Arch Biochem Biophys       Date:  1973-01       Impact factor: 4.013

9.  Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease. I. Studies in cell culture.

Authors:  A E Churchill
Journal:  J Natl Cancer Inst       Date:  1968-10       Impact factor: 13.506

Review 10.  Peroxisomes (microbodies and related particles).

Authors:  C De Duve; P Baudhuin
Journal:  Physiol Rev       Date:  1966-04       Impact factor: 37.312

View more
  1 in total

1.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.